Upgrade to SI Premium - Free Trial

Kitov Pharma (KTOV) Appoints Eric K. Rowinsky, M.D., as Chairman

October 2, 2019 8:21 AM
Kitov Pharma Ltd. (“Kitov”) (NASDAQ: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Changes Management Comments

Next Articles